SCHEMBL5203707

SCHEMBL5203707

CCNP(=O)(Cc1ccc([N+](=O)[O-])cc1)NCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.46
AKR1C3 P42330 1/20 0.45
TSHR P16473 2/20 0.43
ACHE P22303 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
BCHE P06276 1/20 0.43
CYP2C19 P33261 2/20 0.42
CYP1A2 P05177 1/20 0.42
IDO1 P14902 2/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
POLB P06746 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
RECQL P46063 1/20 0.42
CHRM2 P08172 1/20 0.41
PTPRF P10586 1/20 0.41
PTPN2 P17706 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL28801129 0.78 AKR1C3 (0.50) MAPTLOXL2AKR1C3TSHRACHE
SCHEMBL2038554 0.77 LOXL2 (0.50) MAPTLOXL2AKR1C3TSHRACHE
SCHEMBL2034978 0.77 LOXL2 (0.53) MAPTLOXL2AKR1C3TSHRACHE
SCHEMBL5206966 0.76 LOXL2 (0.48) MAPTLOXL2AKR1C3TSHRACHE
SCHEMBL2031961 0.75 CA1 (0.56) MAPTLOXL2AKR1C3TSHRACHE
SCHEMBL21815480 0.74 AKR1C3 (0.57) LOXL2AKR1C3TSHRACHECA1
SCHEMBL78561 0.73 CA1 (0.58) MAPTLOXL2AKR1C3TSHRACHE
Butane SCHEMBL28792796 0.73 HSD17B10 (0.64) MAPTLOXL2TSHRACHECA1
SCHEMBL11040755 0.73 AKR1C3 (0.61) LOXL2AKR1C3TSHRCA1CA2
SCHEMBL916699 0.73 AKR1C3 (0.61) LOXL2AKR1C3TSHRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040103-B1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2007-03-14 EP disclosed
US-6268354-B1 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-07-31 US disclosed
US-6172061-B1 AIDS THERAPY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-09 US disclosed
EP-1039899-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
EP-1040103-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
WO-1999032100-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed
WO-1999032468-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed